| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| STEMVAC | EP-101 | Phase 2 Clinical | Epithany | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; HR-positive breast cancer; Lung Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| BC-3195 | BC3195; BC-3195 | Phase 2 Clinical | Wuxi BioCity | Neoplasm Metastasis; Neoplasms; Solid tumours | 詳細 |
| FF-21101-Y-90 | FF-21101-Y-90; PPMX-T002 | Phase 1 Clinical | Fujifilm Holdings Corp | Solid tumours | 詳細 |
| FF-21101 | FF-21101 | Phase 1 Clinical | Perseus Proteomics Inc | Bile Duct Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours | 詳細 |
| TRAILR2/CDH3 bispecific antibody (Boehringer Ingelheim) | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Neoplasms | 詳細 | |
| AMG 305 | AMG 305; AMG-305 | Phase 1 Clinical | Amgen Inc | Solid tumours | 詳細 |
| FF-21101In | FF-21101In | Phase 1 Clinical | PeptiDream Inc | Solid tumours | 詳細 |